Guizhou Sanli Pharmaceutical Co Ltd
SSE:603439
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Guizhou Sanli Pharmaceutical Co Ltd
SSE:603439
|
CN |
|
Refex Industries Ltd
NSE:REFEX
|
IN |
|
Savencia SA
OTC:BNGRF
|
FR |
|
K
|
Kowloon Development Co Ltd
F:KOX
|
HK |
|
Summa Silver Corp
F:48X
|
CA |
|
Wowjoint Holdings Ltd
OTC:BWOWF
|
CN |
|
C
|
Comet Industries Ltd
XTSX:CMU
|
CA |
|
D
|
Devmar Equities Inc
OTC:DEVM
|
US |
|
T
|
Tera Data Indonusa Tbk PT
IDX:AXIO
|
ID |
|
C
|
Chigo Holding Ltd
F:63C
|
HK |
|
Groupe Plus Values SA
PAR:MLPVG
|
FR |
|
P
|
PSI Software SE
SWB:PSAN
|
DE |
|
Bumi Citra Permai Tbk PT
IDX:BCIP
|
ID |
|
L
|
Longvie SA
BCBA:LONG
|
AR |
|
G
|
Gravity Co Ltd
F:GD8A
|
KR |
|
N
|
NGX Ltd
F:V9S
|
AU |
|
L
|
Lungyen Life Service Corp
TPEX:5530
|
TW |
|
E
|
Elmer Bancorp Inc
OTC:ELMA
|
US |
|
C
|
Caduceus Software Systems Corp
OTC:CSOC
|
US |
|
E
|
E Med Future Inc
OTC:EMDF
|
US |
|
G
|
Gulf Resources Inc
F:R29B
|
CN |
|
Beaconsmind AG
F:81D
|
CH |
|
Encompass Compliance Corp
OTC:ENCC
|
US |
|
D
|
DBM Global Inc
OTC:DBMG
|
US |
Dividends
Dividend Yield
Guizhou Sanli Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Guizhou Sanli Pharmaceutical Co Ltd
Payout Ratio
Guizhou Sanli Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Guizhou Sanli Pharmaceutical Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Guizhou Sanli Pharmaceutical Co Ltd
| Average Annual Return | 2.53% |
| Standard Deviation of Annual Returns | 33.23% |
| Max Drawdown | -52% |
| Market Capitalization | 5.3B CNY |
| Shares Outstanding | 403 840 000 |
| Percentage of Shares Shorted |
N/A
|
